The ability of skin to regenerate hair follicles during wound healing has been clearly shown in rodents 1,2 . In contrast, cutaneous wounds in adult humans typically result in fibrotic repair without regeneration of hair follicles. Investigators have speculated that the immune system is responsible for this scarring response, given that wound healing during fetal development, when the immune system is immature, leads to normal skin and hair follicle regeneration 3 . However, particularly in well-studied mouse models, the immune system is considered an important contributor to cutaneous wound healing. Specifically, epidermal γδ T cells produce factors, such as Fgf7, Fgf10 and IGF1, that are important for keratinocyte survival, proliferation and migration [4] [5] [6] . Here, we determined that dermal γδ T cells initiate an Fgf9-Wnt feedback loop necessary for hair follicle regeneration in wounds.
The ability of skin to regenerate hair follicles during wound healing has been clearly shown in rodents 1, 2 . In contrast, cutaneous wounds in adult humans typically result in fibrotic repair without regeneration of hair follicles. Investigators have speculated that the immune system is responsible for this scarring response, given that wound healing during fetal development, when the immune system is immature, leads to normal skin and hair follicle regeneration 3 . However, particularly in well-studied mouse models, the immune system is considered an important contributor to cutaneous wound healing. Specifically, epidermal γδ T cells produce factors, such as Fgf7, Fgf10 and IGF1, that are important for keratinocyte survival, proliferation and migration [4] [5] [6] . Here, we determined that dermal γδ T cells initiate an Fgf9-Wnt feedback loop necessary for hair follicle regeneration in wounds.
RESULTS

Fgf9 mediates wound-induced hair neogenesis
In the wound-induced hair neogenesis model, a 2.25 cm 2 fullthickness excisional wound is created on the backs of adult C57BL/6 mice. New hair follicle placodes appear after complete wound reepithelialization, which occurs at post-wound day 14 (PWD14, see Fig. 1a for WIHN timeline). Reasoning that important inductive events may occur before hair follicle placode formation, we compared gene expression profiles from whole skin during late wound healing. Fgf9 was differentially expressed before hair follicle formation. We then used qPCR to show that Fgf9 expression increased steadily in wound dermis during late healing but was not detected in the wound epidermis (Fig. 1b) . These results show that Fgf9 is upregulated in the wound dermis before the detection of new hair follicle placodes and potentially during a time of hair follicle fate determination.
To address the importance of Fgf9 in hair follicle neogenesis after wounding, we injected a neutralizing antibody to Fgf9 (anti-Fgf9) into the wound dermis every day for 4 d before hair follicle placode formation. Wounds treated with anti-Fgf9 showed a significant reduction (P < 0.01) in new hair follicle formation when compared with controls injected with an equal concentration of isotype-matched antibody (Fig. 1c) . To test whether increased expression of Fgf9 in the wound promotes WIHN, we overexpressed Fgf9 in the epidermis of FVB-Tg(KRT14-rtTA)F42Efu/J; TRE-Fgf9-IRES-EGFP (K14rtTA; Fgf9) transgenic mice. Administration of doxycycline to these mice induces expression of Fgf9 targeted to the epidermis by the promoter for the gene encoding keratin-14. Fgf9 expression increased 150-fold in these mice after doxycycline administration (Fig. 1d) , and this led to a marked increase in the number of neogenic hair follicles compared to controls (Fig. 1e,f) . These combined results indicate that modulation of Fgf9 expression in the wound affects WIHN.
Dermal gd T cells are the initial source of Fgf9
Peripheral blood γδ T cells are known to produce Fgf9 in humans 7 . To determine whether γδ T cells are the source of wound dermal Fgf9 and to determine their possible importance to WIHN, we studied the timing of entry of these cells into the wound dermis of C57BL/6 mice and engineered mice expressing eGFP in the nuclei of their γδ T cells (Tcrd-H2BEGFP mice 8 ). γδ T cell numbers increased in the wound dermis just before the detection of Fgf9 (Fig. 2a,b) . Vγ3 + dendritic epidermal T cells (Garman nomenclature), evident at the epidermal wound edge and in adjacent hair follicles, typically did not migrate far into the newly made wound epidermis or dermis (Fig. 2a) . During the early period of γδ T cell entry into the wound (PWD9), most γδ T cells were dividing (Fig. 2c,d) , suggesting that the wound environment provides important activation cues for these cells.
Vγ2 + γδ T cells have been described as key contributors to inflammation in skin dermis 9, 10 . Vγ4 + γδ T cells are normal residents of nasal mucosa 11 and skin dermis (Supplementary Fig. 1 ). Our initial research showed that Vγ2 + γδ T cells represent approximately 28% of normal back-skin γδ T cells and 5-10% of the wound-dermis γδ T cell population during late healing (Fig. 2a,b) . Their reduced numbers in the wound suggested that they might not have a major role in latestage wound healing. RT-PCR revealed both Vγ2 + and Vγ4 + T cell subtypes predominating in late-stage wounds (Fig. 3a) .
To determine the source of Fgf9, we sorted PWD12 epidermal and dermal cells into three populations: major histocompatibility complex (MHC) class II-bearing cells (Langerhans cells, B cells, monocytes and macrophages), γδ T cells and double-negative cells (fibroblasts, αβ T cells, neutrophils and others). We sorted the dermal γδ T cell population further into Vγ2 + and Vγ2 − populations (Fig. 3b) .
We performed qPCR analyses of the sorted populations and found that dermal Vγ4 + γδ T cells are the primary source of Fgf9 at this time point in wound healing (Fig. 3b) . Double-negative cells also showed low levels of Fgf9 expression, suggesting that an Fgf9-producing subpopulation exists within this group. Dendritic epidermal T cells were not an Fgf9 source. In situ hybridization localized Fgf9 expression to γδ T cells within the wound dermis of Tcrd-H2BEGFP mice during this time period, supporting the qPCR results (Fig. 3c) .
To determine whether γδ T cells have a role in WIHN, we wounded wild-type (WT) mice and mice lacking γδ T cells (Tcrd −/− mice). Tcrd −/− mice showed normal embryonic hair follicle development as determined by follicle morphology and number ( Supplementary  Fig. 2 and data not shown). Wound healing times in Tcrd −/− mice lagged slightly (0.5-1 d) behind WT mice. This trend was much less notable than previously reported 4 , probably owing to larger wound sizes and longer healing times.
Tcrd −/− mice showed significant defects in WIHN, with reductions of >60% in hair follicle numbers compared with WT controls (P < 0.001, Fig. 3d) . To address the concern that γδ T cells may have a role in WIHN other than the production of Fgf9, we asked whether mice lacking Fgf9 specifically in T cells, including γδT cells, showed reduced WIHN. We first established by qPCR that γδ T cells are the only T cell source of Fgf9 in the wound (Supplementary Fig. 3 ). Transgenic mice lacking Fgf9 in T cells (Lck-Cre; Fgf9 fl/fl ) showed markedly fewer new hair follicles compared to single transgene controls, comparable to the reduction of WIHN in Tcrd −/− mice (Fig. 3e,f) . These mice showed healing times comparable to WT and heterozygous littermates. These combined results demonstrate that Fgf9, expressed by γδ T cells in the late wound dermis, is an important contributor to WIHN. Fgf9 promotes dermal Wnt activation that induces WIHN Fgf9 has been shown to activate canonical Wnt signaling during lung development through the induction of Wnt expression by mesenchymal cells 12, 13 . We reasoned that Fgf9 may induce Wnt activation in the wound. Analysis of dermal Wnt activation in wounds of Wnt-reporter mice (Axin2-LacZ heterozygotes) revealed increased activity in late-stage wounds with abatement around PWD16 when Axin2 concentrated predominantly in new hair follicle placodes of the epithelium (Fig. 4a) . Analyses of PWD12 dermis for nuclear β-catenin and Lef1, other important indicators of Wnt activity, confirmed results observed in wounds of Axin2-LacZ mice ( Supplementary Fig. 4 ). These data indicate that dermal Wnt activation is a component of late healing and, as in embryonic development, a key first step for hair follicle neogenesis 14 .
To test the hypothesis that Fgf9 from γδ T cells is the catalyst for dermal Wnt activation, Axin2-LacZ; Tcrd −/− mice were wounded and analyzed for Axin2-LacZ expression (Fig. 4a,b) . Axin2-LacZ expression in Tcrd −/− PWD12 dermis and PWD14 epidermis and dermis was markedly reduced compared to control Axin-LacZ mice. qPCR confirmed that wound dermis of Tcrd −/− mice had reduced expression of Axin2 and Lef1 compared to WT controls (Fig. 4c) . Reduced Axin2 expression did not appear to affect healing, as wounds of both WT and Tcrd −/− mice showed comparable reepithelialization and dermal remodeling and in similar time frames (Fig. 4a,b) .
We previously showed that forced overexpression of Wnt7a in epidermis of the Krt14-Wnt7a mouse leads to markedly more WIHN compared to WT controls 1 . To determine whether overexpression of Wnt7a in the epidermis could rescue WIHN in our model, we analyzed Krt14-Wnt7a; Tcrd −/− (Wnt7a; Tcrd −/− ) mice and controls for WIHN. As previously reported, wounds of Krt14-Wnt7a (Wnt7a) control mice had large numbers of new hair follicles 1 (Fig. 4d,e) . In marked contrast, wounds of Wnt7a; Tcrd −/− mice showed significantly less WIHN (P < 0.01). This result was surprising because, in embryonic hair follicle development, overlying epidermis provides the necessary Wnt source for dermal Wnt activation 14 . However, because dermal Wnt activity preceded reepithelialization in the wound (see Fig. 4a ), epidermal Wnt might arrive too late to rescue the phenotype in this model. In support of this, PWD12 wound dermis of Wnt7a; Axin2-LacZ mice showed no difference in Axin2 expression, and therefore in dermal Wnt activity, compared with that of Axin2-LacZ mice (Fig. 4f) . As expected, amplified Wnt activity was observed in the surrounding unwounded skin of Wnt7a; Axin2-LacZ mice (Fig. 4f) .
To address whether Fgf9 could rescue WIHN in mice lacking γδ T cells, we injected adenovirus containing either an Fgf9 construct (AdFgf9) or a control GFP construct (AdGFP) into the PWD9 dermis of Axin2-LacZ; Tcrd −/− mice. Augmented Axin2 expression was observed in AdFgf9-treated but not AdGFP-treated wounds at PWD12 (Fig. 4g) . Analysis of WIHN showed a significantly higher number of Ki-67
Ki-67 npg new hair follicles in AdFgf9-treated mice (P < 0.05, Fig. 4h ). These data confirm that exogenous Fgf9 can induce Wnt activity in wounds and positively influence WIHN. Because treatment did not fully restore WIHN, other, as yet unknown, γδ T cell-mediated effects may also affect WIHN.
Fgf9 from gd T cells initiates a feedback loop
During lung development, Fgf9 induces canonical Wnt2a ligand expression in mesenchymal cells 12 . In initial experiments, we found that Wnt2a was expressed in normal wound dermis and reduced in Tcrd −/− dermis, suggesting that Wnt2a might also have a role in wound healing (Fig. 4b,c) . Reasoning that wound fibroblasts might be the target of Fgf9 activation, we first established that FgfR2 and FgfR3, both high affinity receptors for Fgf9 (ref. 15) , were present in fibroblasts from WT and Tcrd −/− wound dermis (Supplementary Fig. 5 ).
We then cultured wound fibroblasts in the presence or absence of Fgf9 and evaluated expression of Wnt2 and an unrelated canonical Wnt (Wnt10a). Fibroblasts cultured with exogenous Fgf9 expressed substantially higher levels of Wnt2 but not Wnt10a transcripts (Fig. 5a) . Tcrd −/− fibroblasts showed similar results, indicating that these cells are capable of Wnt2 expression if provided with Fgf9.
We also compared sorted wound fibroblasts from WT mice and Tcrd −/− mice for Wnt2 expression during late healing (Fig. 5b) (the sorting strategy for fibroblasts is found in Online Methods and Supplementary Fig. 6 ). WT wound fibroblasts, but not Tcrd −/− fibroblasts, showed an increase in Wnt2 expression over time. These results further support a role for γδ T cell-secreted Fgf9 in the induction of Wnt2 by fibroblasts and subsequent Wnt activation in vivo.
Unexpectedly, sorted WT fibroblasts, but not Tcrd −/− fibroblasts, also showed increased expression of Fgf9 (Fig. 5b) . To determine when fibroblasts initiated Fgf9 gene expression compared to γδT cells in vivo, we established a timeline of Fgf9 expression for both (Fig. 5c) . Comparisons showed that early in this window, γδT cells were the primary source of Fgf9 in the wound, but fibroblasts had higher Fgf9 expression during later healing. In situ hybridization comparing Fgf9 expression in PWD11, PWD12 and PWD14 wounds supported this finding (Supplementary Fig. 7 ). Because WT, but not Tcrd −/− , fibroblasts showed upregulation of Fgf9 expression in vivo (1-2 d after γδ T cell Fgf9 expression), we reasoned that this new gene expression might be a consequence of Wnt activation.
Fgf9 has been shown as a canonical Wnt target in endometrioid adenocarcinomas 16 . To address the possibility that Fgf9 is a Wnt target Scale bar, 1 mm. Data are expressed as means ± s.e.m. **P < 0.01, ****P < 0.001 compared to controls, calculated using two-tailed Student's t test.
npg in wounds, we cultured dermal wound fibroblasts with increasing amounts of recombinant Wnt2a protein over 3 d. Culture supernatants, when tested for Fgf9 protein by ELISA, showed increasing expression of Fgf9 over time (Fig. 5d) . These data reveal Fgf9 as a target of Wnt activation in wound fibroblasts. These combined data show that Fgf9, secreted by γδ T cells during PWD10-12, acts as the catalyst for regional dermal fibroblast Wnt2a expression and subsequent Wnt activation (Fig. 5e) . In turn, this activation induces further expression of Fgf9 from fibroblasts, which serves to perpetuate and amplify Wnt activation throughout the entire dermis during a crucial phase for WIHN. Although others have shown the ability of Fgf9 to induce Wnt activation 12, 13 and Wnt activation to induce expression of Fgf9 (ref. 16) , to our knowledge, these data are the first to link these important signaling cascades in an amplification loop (Fig. 5e) .
Humans lack a robust population of dermal gd T cells Humans lack appreciable hair follicle regeneration after wounding compared to mice. To understand whether differences in immune cells may explain this deficiency, we compared relative numbers and locations of γδ T cells within the dermis of normal mouse and human skin (Fig. 6) . In line with other work 9,17-22 , we found that human dermis showed a notable paucity of resident γδ T cells in number and density per area compared with mouse dermis (Fig. 6a-d) . 
npg
We also noted a difference in location of mouse and human dermal γδ T cells. Mouse γδ T cells were dispersed throughout the dermis, typically away from αβ T cells and blood vessels (Fig. 6e,f) . In contrast, human γδ T cells clustered with αβ T cells in vascularized dermal 'pockets' (Fig. 6e,f) , suggesting that they transit between skin and blood at least infrequently. The low number and sequestered location of γδ T cells in human compared to mouse skin may explain the poor regenerative response of human skin to wounding.
DISCUSSION
Wnt signaling pathways used for hair follicle development are mirrored in WIHN. We showed previously that epidermal Wnt activation is a necessary component of WIHN, as it is for hair follicle development 1, 23, 24 . Here, we show that early dermal Wnt activation is also requisite for hair follicle regeneration. Indeed, this model provides an opportunity to uncouple epidermal and dermal contributions to hair follicle regeneration because overlying epidermis is absent during initial dermal Wnt activation. Also, overexpression of epidermal Wnt after reepithelialization does not contribute to dermal Wnt activation and is insufficient to trigger WIHN. During embryogenesis, dermal Wnt activation has been known as an early event in skin maturation and postulated as the first signal for hair induction 24, 25 . However, only recently has this hypothesis been formally substantiated. In the absence of either epidermal Wnts 14, 26 or dermal Wnt activation 14 , hair follicle placodes did not form, designating Wnt activation as an essential early step in hair follicle development.
In the wound, we have shown that γδ T cells produce Fgf9, which induces fibroblast Wnt expression, ultimately leading to WIHN. In development, the upstream signal driving Wnt expression in epidermis remains unknown. Recently, Fgf20, a member of the Fgf9 family, was implicated in feather-placode induction in chickens 27 . The scaleless mutation, manifested by the complete lack of patterned placode formation and subsequent feathers, has been mapped to the gene encoding Fgf20 (refs. 27,28) . In the mouse, however, genetic loss of Fgf20 permits placode but not guard hair dermal condensate formation, thus pointing to a function downstream of placode specification 29 . Indeed, these mice lack guard hairs but maintain other hair types, albeit at lower densities. These results suggest possible redundancy with other Fgf9 family members in inducing early epidermal Wnt expression in mice. Alternatively, mechanisms other than Fgf signaling may serve to upregulate mouse epidermal Wnts during skin development.
Although dermal Wnt activation is necessary for hair follicle development and regeneration, its role remains unknown. Chen et al. 14 showed fibroblast proliferation after dermal Wnt activation, and we have noted considerable dermal proliferation in wounds during late healing (Supplementary Fig. 1c) . However, fibroblast proliferation probably reveals only a part of the story. In development and late healing, epidermal Wnt activation closely follows dermal activation. Chen et al. 14 proposed that dermal Wnt activation drives epidermal Wnt activation, presumably through a soluble dermal 'factor' . In WIHN, we showed that wound fibroblasts secrete Wnts in response to Fgf9-mediated cues. Increased Wnt expression in the dermis may augment epidermal Wnt concentrations, overcoming a threshold for triggering epidermal activation and hair follicle formation. In embryogenesis, Wnts and Wntless, a cargo protein required for Wnt secretion, are expressed in both early embryonic epidermis and dermis 25, 26 . However, loss of dermal Wntless does not seem to affect epidermal Wnt activity or the subsequent development of hair follicles, suggesting other, as yet unknown, mechanisms 14 .
As outlined above, early signaling pathways for hair follicle induction in development and WIHN are probably the same. However, the cells that drive these induction events are different. γδ T cells provide initial Fgfs for Fgf signaling and fibroblasts provide Wnts for dermal Wnt activation in WIHN, whereas the epidermis probably provides these factors in development. These examples illustrate the parallels and important differences between skin development and regeneration in response to wounding and demonstrate the positive impact of the immune system on tissue renewal.
Our Fgf9 overexpression studies support the notion that wounding produces a window of opportunity to push regenerating epidermis toward a hair follicle fate. The introduction of AdFgf9 to γδ T cell-deficient mouse skin during wounding compensated for lack of Fgf9 and resulted in increased numbers of hair follicles, thus indicating the potential for using Fgf9 to manipulate hair follicle regeneration. Future studies testing activators of the Fgf or Wnt pathways during wound healing may be warranted to determine their effects on hair follicle regeneration. This avenue of research could lead to new approaches for promoting hair growth in patients with hair loss.
METHODS
Methods and any associated references are available in the online version of the paper.
